Cargando…
Preparation, characterization, and Co-delivery of cisplatin and doxorubicin-loaded liposomes to enhance anticancer Activities
Ovarian cancer stands as a leading cause of cancer-related deaths among women globally. This malignancy has hindered successful treatment attempts due to its inherent resistance to chemotherapy agents. The utilization of cisplatin and doxorubicin-loaded liposomes emerges as a strategically advantage...
Autores principales: | Bahrami Parsa, Mahdi, Tafvizi, Farzaneh, Chaleshi, Vahid, Ebadi, Mostafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560846/ https://www.ncbi.nlm.nih.gov/pubmed/37818003 http://dx.doi.org/10.1016/j.heliyon.2023.e20657 |
Ejemplares similares
-
Cholesterol Derivatives Based Charged Liposomes for Doxorubicin Delivery: Preparation, In Vitro and In Vivo Characterization
por: Nie, Yu, et al.
Publicado: (2012) -
Preparation and evaluation of a Rubropunctatin-loaded liposome anticancer drug carrier
por: Xu, Dongling, et al.
Publicado: (2020) -
Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma
por: Wei, Minyan, et al.
Publicado: (2015) -
Preparation, Characterization, and Evaluation of Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved In Vitro and In Vivo Anticancer Activities
por: Ghaferi, Mohsen, et al.
Publicado: (2020) -
Preparation and Characterization of Electrostatically Crosslinked Polymer–Liposomes in Anticancer Therapy
por: Chiang, Yi-Ting, et al.
Publicado: (2018)